Medication info
Alendronate Sodium 150 mg (Sodium Alendronate 2.5 Hydrate)

Alendronate Sodium 150 mg (Sodium Alendronate 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›172.1mg / 1 tablet
Manufacturer / importer
Yooyoung Pharmaceutical Co., Ltd.
Appearance
Bright blue oval film-coated tablet
Packaging
1 tablet (1 tablet/PTP packaging X 1)
Approval status
Active

MFDS item code 201001731 · Notified 2010.02.26 · Insurance code 648203310

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
1. Adults : Administer 150 mg of risedronate sodium orally once a month. 2. Older adults : No dose adjustment is necessary because the bioavailability and pharmacodynamics of this medicine in older adults (over 60 years) are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose again on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
Child dose
Safety and efficacy have not been established in children under 18 years.

Ingredients

Manufacturer
Yooyoung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.

How to take

Adult dose

1. Adults : Administer 150 mg of risedronate sodium orally once a month. 2. Older adults : No dose adjustment is necessary because the bioavailability and pharmacodynamics of this medicine in older adults (over 60 years) are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose again on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.

Child dose

Safety and efficacy have not been established in children under 18 years.

Precautions

This medication may irritate the gastrointestinal mucosa, so caution is needed for those with upper gastrointestinal disorders. In particular, patients with esophageal diseases, gastritis, duodenitis, or ulcers should consult a doctor before taking this medication. It is essential to take this medication with a sufficient amount of water, and the patient should not lie down for at least 30 minutes after taking it. This medication should not be administered to patients with certain esophageal abnormalities, hypocalcemia, women who are pregnant or may become pregnant, or patients with severe renal impairment. Additionally, individuals with lactose intolerance should not take this medication. It is important to maintain adequate intake of calcium and vitamin D while on this medication, and caution should be exercised when taking it with drugs containing divalent cations such as calcium or magnesium, as absorption may be hindered. If symptoms such as esophagitis, dysphagia, chest pain, or heartburn occur during use, the patient should immediately stop taking the medication and consult a doctor. Long-term use may rarely lead to side effects such as fractures or osteonecrosis of the jaw, so regular check-ups are necessary. The administration of this medication during pregnancy or breastfeeding should be avoided or done according to a doctor's guidance. Safety has not been established for use in children, so it is advisable not to use this medication in pediatric patients. In case of overdose, serum calcium and phosphate levels may decrease, and prompt medical attention should be sought.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • infection
  • low back pain
  • accidental injury
  • pain
Show 58 more
  • abdominal pain
  • flu symptoms
  • headache
  • lethargy
  • throat pain
  • chest pain
  • allergic reaction
  • hypertension
  • constipation
  • diarrhea
  • dyspepsia
  • nausea
  • peripheral edema
  • arthralgia
  • arthritis
  • fracture
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased coughing
  • rash
  • cataract
  • urinary tract infection
  • vomiting
  • uveitis
  • scleritis
  • iritis
  • skin and mucous membrane syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • skin reaction
  • external auditory canal osteonecrosis
  • jaw osteonecrosis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air from entering and kept at a temperature between 1°C and 30°C. Storing it this way helps maintain the drug's efficacy and prevents degradation.

Appearance and packaging

Appearance

Bright blue oval film-coated tablet

Package unit

1 tablet (1 tablet/PTP packaging X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.